|
|
Publication
|
| Title of Article |
Reliability and Validity of Mini-Balance Evaluation System Test in Type 2 Diabetic Patients with Peripheral Neuropathy |
| Date of Acceptance |
6 June 2022 |
| Journal |
| Title of Journal |
International journal of environmental research and public health (IJERPH) |
| Standard |
OTHER (JCR - Q1) |
| Institute of Journal |
Journal by MDPI |
| ISBN/ISSN |
ISSN: 1660-4601 |
| Volume |
2022 |
| Issue |
June |
| Month |
Voulume 19, Issue 11 |
| Year of Publication |
2022 |
| Page |
12 |
| Abstract |
Type 2 diabetic peripheral neuropathy is known to cause balance limitations in static,
dynamic, and functional activity. The Mini-BESTest, a shortened version of BESTest, was evolved
to identify balance disorders within a short duration. No prior studies have yet been conducted
to assess the usefulness of Mini-BESTest in the diagnosis of type 2 diabetic peripheral neuropa-
thy. The current study aimed to examine the reliability and discriminant validity by comparing
the Mini-BESTest scores between type 2 diabetic patients with peripheral neuropathy, divided into
two 2 groups based on reporting scores of <4 and ≥4 in the MNSI questionnaire, respectively. There-
fore, a cross-sectional study design was conducted including 44 type 2 diabetic patients ( 4 males
and 40 females; aged 56.61 ± 7.7 years old). Diabetic peripheral neuropathy was diagnosed by
physical assessment using the Michigan Neuropathy Screening Instrument (MNSI). Inter-rater
(two physiotherapists) and Intra-rater (7–10 days) reliability of the Mini-BESTest were explored
with intraclass correlation coefficients (ICC2,1) and (ICC3,1). The Mini-BESTest presented an excel-
lent inter-rater reliability (ICC2,1= 0.95, 95% CI = 0.91–0.97, SEM = 0.61) and an excellent intra-rater
reliability (ICC3,1 = 0.93, 95% CI = 0.87–0.96, SEM = 0.66), with confirmation by a good agreement
presented by the Bland–Altman plots. The internal consistency measured with the overall Cronbach’s
alpha showed an acceptable agreement (0.73). The MDC was 2.16. In addition, the Mini-BESTest
scores in the type 2 diabetic neuropathy patients reporting MNSI questionnaire scores <4 was found
to be significantly higher when compared with those reporting scores ≥4. The Mini-BESTest can
be used as a highly reliable and valid clinical application in the population with type 2 diabetic
peripheral neuropathy. |
| Keyword |
balance; diabetic peripheral neuropathy; Mini-BESTest |
| Author |
|
| Reviewing Status |
มีผู้ประเมินอิสระ |
| Status |
ตีพิมพ์แล้ว |
| Level of Publication |
นานาชาติ |
| citation |
true |
| Part of thesis |
true |
| Attach file |
|
| Citation |
0
|
|
|
|
|
|
|
|
|
Journal Publication
ไทย